Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endologix secures $20m in equity placement to expand sales network:

This article was originally published in Clinica

Executive Summary

Endologix has raised $20m through the direct placement of 6.1 million shares with several unnamed institutional investors. The proceeds will enable the Irvine, California company to grow its sales force to 40-50 representatives by the end of the year and expand its marketing efforts in the US to commercialise its flagship product, the Powerlink system designed as a minimally-invasive treatment of abdominal aortic aneurysms. "Importantly, we believe we now have sufficient capital resources to operate our business to cash flow-positive operations," added Paul McCormick, Endologix' president and CEO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051959

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel